Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell -- like subypes of diffuse large B-cell lymphoma.
| Autor: | Fu K, Weisenburger DD, Choi WWL, Perry KD, Smith LM, Shi X, Hans CP, Greiner TC, Bierman PJ, Bociek RG, Armitage JO, Chan WC, Vose JM |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 10/1/2008, Vol. 26 Issue 28, p4587-4594, 8p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|